Marksans Pharma gains on stock split proposal

Marksans Pharma gained 2.55% Rs 342.10 at 14:14 IST on BSE, after the company said its board will consider stock split at a meeting to be held on 25 January 2008.

The company made this announcement during trading hours today, 8 January 2008.

Meanwhile, BSE Sensex was down 48.84 points or 0.23% to 20,763.81.

On BSE, 3.37 lakh shares were traded in the counter. The stock had an average daily volume of 2.49 lakh shares in the past one quarter.

The stock hit a high of Rs 348.80 and a low of Rs 317.20 so far during the day. The stock hit a 52-week high of Rs 351.60 on 4 January 2008 and a 52-week low of Rs 44.20 on 14 June 2007.

The mid-cap scrip had outperformed the market over the past one month till 7 January 2008, gaining 94.52% as compared to the Sensex's return of 4.24%. It had also outperformed the market in the past one quarter, rising 184.28% as compared to the Sensex's rise of 13.85%.

The company's current equity is Rs 35.94. Face value per share is Rs 10.

The current price of Rs 342.10 discounts Q2 September 2007 annualized EPS of Rs 3.88 by a PE multiple of 88.17.

On 1 January 2008, the company signed an agreement with UK's Hale Group to buy it out along with its subsidiary.

Marksans Pharma's net profit declined 40.2% to Rs 3.49 crore on 23.8% fall in net sales to Rs 54.41 crore in Q2 September 2007 over Q2 September 2006.

The company is engaged manufacturing and selling pharmaceuticals

Popular posts from this blog

IOB capitalises on hike in stake by LIC

Lok Housing & Constructions builds on fund raising plans

economic times picks